These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5069316)

  • 81. [Endotoxins of Gram-negative bacteria in liver diseases].
    Bréchot C; Hecht Y; Ferrier JP
    Gastroenterol Clin Biol; 1980 Apr; 4(4):289-305. PubMed ID: 6765202
    [No Abstract]   [Full Text] [Related]  

  • 82. Cerebral edema in the rat with galactosamine induced severe hepatitis.
    Gröflin UB; Thölen H
    Experientia; 1978 Nov; 34(11):1501-3. PubMed ID: 720486
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthesis of LDL-apoproteins in D-galactosamine-induced hepatitis in rats.
    Nadkarni GD; Pestonjamasp KN
    Indian J Biochem Biophys; 1984 Feb; 21(1):57-8. PubMed ID: 6490058
    [No Abstract]   [Full Text] [Related]  

  • 84. [The significance of age for morphological and biochemical changes in galactosamine hepatitis].
    Platt D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():249-51. PubMed ID: 1029185
    [No Abstract]   [Full Text] [Related]  

  • 85. [Proceedings: Inhibition of autophagocytosis through cycloheximide in rat hepatocytes damaged by D-galactosamine].
    Rumpelt HJ; Albring M
    Verh Dtsch Ges Pathol; 1974; 58():522. PubMed ID: 4460541
    [No Abstract]   [Full Text] [Related]  

  • 86. [Protective effect of Polyporus umbellatus polysaccharide on toxic hepatitis in mice].
    Lin YF; Wu GL
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):345-8. PubMed ID: 3195347
    [No Abstract]   [Full Text] [Related]  

  • 87. [Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].
    Pausch J; Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1972; 78():1375-7. PubMed ID: 4665550
    [No Abstract]   [Full Text] [Related]  

  • 88. [Morphological changes in rat liver in toxic drug-induced hepatitis and stimulation of repair processes].
    Sadovnikova VV; Sadovnikova IV; Ivanova NL
    Morfologiia; 2001; 120(6):63-5. PubMed ID: 12016768
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Modelling of acute liver failure in rabbits].
    Farber NA; Ketiladze ES; Gubskiĭ LV; Erokhina LG; Braginskiĭ DM
    Biull Eksp Biol Med; 1982 Jun; 93(6):41-5. PubMed ID: 7115932
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Haemostasis during galactosamine hepatitis].
    Krause W; Hey D; Leinweber B
    Klin Wochenschr; 1972 Apr; 50(7):386-7. PubMed ID: 5026045
    [No Abstract]   [Full Text] [Related]  

  • 91. Changes in chromatin during the development of liver cell injury induced by galactosamine.
    Weiss E; Gross V; Heinrich PC
    FEBS Lett; 1976 Apr; 64(1):193-96. PubMed ID: 1269752
    [No Abstract]   [Full Text] [Related]  

  • 92. [Behavior of lysosomal enzymes in the genesis of galactosamine induced hepatitis].
    Heissmeyer H; Stein U; Grub R; Lesch R; Reutter W
    Naturwissenschaften; 1971 Jul; 58(7):369-70. PubMed ID: 5569297
    [No Abstract]   [Full Text] [Related]  

  • 93. [Non-A, non-B hepatitis in hemodialysis patients: medicamentous etiology].
    Simon P; Meyrier A; Menault M; Bombail D
    Nouv Presse Med; 1979 Mar; 8(14):1186. PubMed ID: 461151
    [No Abstract]   [Full Text] [Related]  

  • 94. [Influence of bilateral adrenalectomy on acute galactosamine lesions in the rat].
    Lesch R; Deus B; Reutter W
    Verh Dtsch Ges Inn Med; 1972; 78():1380-3. PubMed ID: 4665552
    [No Abstract]   [Full Text] [Related]  

  • 95. [Use of pentoxyl and methyluracil (methacil) in liver diseases (literature review)].
    Vitlin VI
    Klin Khir (1962); 1971 Mar; 3():71-5. PubMed ID: 4941177
    [No Abstract]   [Full Text] [Related]  

  • 96. New hepato-protective agents. I. Maleopimaric acid-4alpha-carboxamides.
    Danswan GW; Ramm PJ; Taylor JB
    Arzneimittelforschung; 1976; 26(12):2188-9. PubMed ID: 1037271
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Drug-induced allergic hepatitis: does isaxonine fall into this category?
    Pohl LR
    Hepatology; 1989 May; 9(5):785-8. PubMed ID: 2707741
    [No Abstract]   [Full Text] [Related]  

  • 98. [Hepatological information].
    Juszczyk J
    Pol Tyg Lek; 1982 Oct; 37(37):1113-6. PubMed ID: 6761664
    [No Abstract]   [Full Text] [Related]  

  • 99. [Proceedings: Pharmacologic studies on influencing of lanthanide-induced liver dystrophy].
    Oberdisse E; Werneke M; Grosse U
    Verh Dtsch Ges Pathol; 1974; 58():520. PubMed ID: 4460539
    [No Abstract]   [Full Text] [Related]  

  • 100. [Variant for creation of an experimental model of toxic hepatitis].
    Glukhova LG
    Patol Fiziol Eksp Ter; 1979; (5):72-3. PubMed ID: 159427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.